Norris Medicines
BSE: NORRIS · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Norris Medicines's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Norris Medicines Limited is an Indian pharmaceutical company that manufactures and markets a diverse range of generic formulations, including injectables, tablets, and capsules. The company operates a manufacturing facility in Ankleshwar and serves both domestic and international markets.
Business Model
The company generates revenue through the manufacturing and sale of pharmaceutical products across various therapeutic segments such as antibiotics, analgesics, and cardiovascular treatments. It focuses on providing affordable generic medicines while adhering to regulatory quality standards.
Growth Outlook
Growth is driven by the company's focus on expanding its generic medicine portfolio and leveraging its manufacturing capabilities to serve both domestic and export markets.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving pharmaceutical manufacturing regulations in both domestic and international markets.
- Market Competition. As a small-cap entity, the company faces intense competition from larger pharmaceutical firms with greater economies of scale.
- Input Cost Volatility. Fluctuations in the prices of active pharmaceutical ingredients and raw materials can significantly impact profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Norris Medicines and 5,000+ companies — free.
Peers · Trading & Distributors
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Norris MedicinesNORRIS | ₹16 Cr | — | — | — | 8.1% | — | — | -2.3% |
Veritas (India)VERITAS | ₹445 Cr | 8.63 | 7.06 | -24.1% | 3.9% | 1.9% | 2.7% | -55.4% |
Kothari ProductsKOTHARIPRO | ₹407 Cr | 179.58 | -12.12 | -18.3% | -5.1% | -0.2% | -2.3% | -9.8% |
Rotographics (India) LimitedRGIL | ₹404 Cr | 94.62 | 326.54 | 4987.7% | 3.0% | 12.6% | 17.2% | — |
Polo Queen Industrial and Fintech LimitedPQIF | ₹333 Cr | 141.71 | 64.71 | -5.7% | 7.0% | 1.3% | 2.5% | -79.1% |
Constronics Infra Ltd.CONSTRONIC | ₹61 Cr | — | — | — | 5.5% | — | — | -24.7% |
As of Mar 2026
Financials
Norris Medicines
BSE: NORRIS · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Norris Medicines's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Norris Medicines Limited is an Indian pharmaceutical company that manufactures and markets a diverse range of generic formulations, including injectables, tablets, and capsules. The company operates a manufacturing facility in Ankleshwar and serves both domestic and international markets.
Business Model
The company generates revenue through the manufacturing and sale of pharmaceutical products across various therapeutic segments such as antibiotics, analgesics, and cardiovascular treatments. It focuses on providing affordable generic medicines while adhering to regulatory quality standards.
Growth Outlook
Growth is driven by the company's focus on expanding its generic medicine portfolio and leveraging its manufacturing capabilities to serve both domestic and export markets.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent and evolving pharmaceutical manufacturing regulations in both domestic and international markets.
- Market Competition. As a small-cap entity, the company faces intense competition from larger pharmaceutical firms with greater economies of scale.
- Input Cost Volatility. Fluctuations in the prices of active pharmaceutical ingredients and raw materials can significantly impact profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Norris Medicines and 5,000+ companies — free.
Peers · Trading & Distributors
As of Mar 2026